XtalPi Funding & Investors
Cambridge, MA
XtalPi is a pharmaceutical technology company that is reinventing the industry’s approach to drug research and development with its Intelligent Digital Drug Discovery and Development (ID4) platform. Through its tightly interwoven quantum mechanics, artificial intelligence, and high-performance cloud computing algorithms, the ID4 platform enables pharmaceutical companies to increase their efficiency, accuracy, and success rate at critical stages of drug R&D. By accelerating the pace of drug discovery and development, XtalPi aims to contribute to a healthier society worldwide.
http://www.xtalpi.com/Total Amount Raised:
XtalPi Funding Rounds
Post Ipo Equity
2,088,000,000 HKD
Post Ipo Equity
1,125,000,000 HKD
Post Ipo Debt
5,000,000,000 CNY
Post Ipo Debt Investors
China Construction BankIPO
Unknown
Series D
$400,000,000
Series D Investors
HOPU InvestmentsOrbiMed AdvisorsSino Biopharmaceutical5Y CapitalHSGTaihill VentureSeries C
$318,800,000
Series C Investors
5Y CapitalPICC Capital Investment ManagementSoftBank Vision FundSIGTencentChina Life Healthcare FundHSGIMO VenturesCITIC Capital HoldingsCMB International's Telecom Fund.Oceanpine CapitalShunweiMirae AssetMorningside CapitalSeries B
$46,000,000
Series B Investors
China Life Healthcare FundYael CapitalSIGHT CapitalSeries B
$15,000,000
Series B Investors
HSGAlphabetTencentSeries A
400,000 CNY
Series A Investors
ZhenFundSeries A
8,000,000 CNY
Series A Investors
Frees FundZhenFundSeries A
$5,000,000
Series A Investors
TencentFrees FundZhenFundAngel
$309,000
Angel Investors
Renren